SYNDROME D'ACTIVATION MACROPHAGIQUE CHEZ L ... - Toubkal

[49]. Imashuku S, Hibi S, Sako M, Ishida Y, Mugishima H et alSoluble interleukin 2 receptor: a useful prognostic factor for patients with hemophagocyticlymphohistiocytosis.Blood 1995; 86: 4706-7.[50] Ishii E, Ohga S, Aoki T, Yamada S, Sako M, Tasaka H, et al.Prognosis of children with virus-associated hemophagocytic syndrome and malignanthistiocytosis: correlation with levels of serum interleukin-1 and tumor necrosis factor.Acta Haematol 1991; 85:93–9[51] Geist L, Monick M, Stinski M, Hunninghake G.The immediate early genes of human cytomegalovirus upregulate TNF-α gene expression.J Clin Invest 1994; 93:474–8.[52] Lay JD, Tsao CJ, Chen JK, Kadin ME, Su LJ.Upregulation of tumor necrosis factor-alpha gene by Epstein-Barr virus and activation ofmacrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocyticsyndrome.J Clin Invest 1997; 100:1969–79.[53] Henter JI, Andersson B, Elinder G, Jakobson A, Lübeck PO, Söder O.Elevated circulating levels of interleukin-1 receptor antagonist but not IL-1 agonist inhemophagocytic lymphohistiocytosis.Med Pediatr Oncol 1996; 27: 21-5.[54] Blaise E Favara.Hémophagocytic lymphohistiocytis : a hémophagocytic syndrome.Semin. Diagn. Pathol, 1992, 9, 63-74[55] R.costello, K.Mazodier, V. Baccini, G. Kaplanski, T.Le Treut, G SébahounLymphohistiocytose hémophagocytaireEMC Hématologie 2007 ; 13-012-G-10[56] Harada S, Sakamoto K, Seeley JK, et al.Immune deficiency in the x-linked lymphoproliferative syndrome. Epstein-Barr virus specificdefects.J Immunol 1982; 129: 2532-2535[57] Saito K., Hirokawa M., Inaba K., Fukaya H., Kawabata Y., Komatsuda A,et al.Phagocytosis of codeveloping megakaryocytic progenitors by dendritic cells in culture withthrombopoietin and tumor necrosis factor-alpha and its possible role in hemophagocyticsyndrome. Blood 2006; 107: 1366-1374204